New Data Presented at EASD Demonstrate Robust Cardiometabolic Health Effects of EndoBarrier® Therapy in Obese People With and Without Diabetes
September 17, 2014GI Dynamics announced new data demonstrating clinically meaningful improvements in the prevalence of metabolic syndrome, as well as a reduction in 10-year CV risk in obese patients treated with EndoBarrier® Therapy.
More »
Microarray technology proves superior to sequencing for non-invasive prenatal testing
September 15, 2014Ariosa Diagnostics, Inc. announced that its scientists have successfully tested and implemented a microarray DNA quantification method for Ariosa's Harmony™ Non-Invasive Prenatal Test (NIPT).
More »
Celator® Pharmaceuticals Announces Publication of Preclinical Data for CPX-351 in Acute Lymphoblastic Leukemia Models
September 15, 2014Celator® Pharmaceuticals announced the publication of preclinical data in Pediatric Blood & Cancer that shows the therapeutic potential of their lead compound, CPFX-351, in hematological malignancies and supports its ongoing clinical testing.
More »